Sérgio Serrano - Concepedia

Author

Sérgio Serrano

Also Known As

M. Jesús Pérez, Ruffo Freitas- Junior, S SERRANO, S Serrano, S V Serrano, S. SERRANO, S. Serrano, S. V. Serrano, S.V. Serrano, SERGIO VICENTE SERRANO

202

Publications

4.1K

Citations

H-Index

Concepts

All Affiliations

Universitat Autònoma de Barcelona Hospital Del Mar Universitat Pompeu Fabra Hospital de Câncer de Barretos Municipal Institute for Medical Research

About

Sérgio Serrano is an author at Universitat Autònoma de Barcelona specializing in medicine, oncology, and pathology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	31	2.2K
2	Health Sciences	5	5	451
3	Nursing	1	1	25
4	Public Health	1	1	25
5	Anatomy	1	1	11

Sérgio Serrano

Publications

3.9K

Citations

H-Index

Page 1

	Year	Citations
AVEREL: A Randomized Phase III Trial Evaluating Bevacizumab in Combination With Docetaxel and Trastuzumab As First-Line Therapy for HER2-Positive Locally Recurrent/Metastatic Breast Cancer Luca Gianni, Gilles Romieu, Sérgio Serrano, Journal of Clinical Oncology First-line TherapyBreast OncologyMedicineImmunologyClinical Trials	2013	255
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial John C. Araujo, Géralyn C. Trudel, Fred Saad, The Lancet Oncology Double-blind Phase 3UrologyGenitourinary CancerMedicineClinical Trials	2013	229
MYC protein expression and genetic alterations have prognostic impact in patients with diffuse large B-cell lymphoma treated with immunochemotherapy Alexandra Valera, Armando López‐Guillermo, Teresa M. Cardesa‐Salzmann, Haematologica ImmunologyPathologyMyc AmplificationsImmunotherapyTumor Biology	2013	225
Cytogenetic aberrations and their prognostic value in a series of 330 splenic marginal zone B-cell lymphomas: a multicenter study of the Splenic B-Cell Lymphoma Group Marta Salido, Cristina Baró, David Oscier, Blood	2010	190
Nuclear PARP-1 protein overexpression is associated with poor overall survival in early breast cancer Federico Rojo, Jetzabel García-Parra, Sandra Zazo, Annals of Oncology Breast OncologyPoor Overall SurvivalEarly Breast CancerMedicineBreast Cancer	2011	177
In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior Alejandra Carvajal-Cuenca, Luz F. Sua, N. M. Silva, Haematologica	2011	159
Increased ALK Gene Copy Number and Amplification are Frequent in Non-small Cell Lung Cancer Marta Salido, Lara Pijuán, Luz Martínez‐Avilés, Journal of Thoracic Oncology Tumor BiologyOncologyMedicinePathologyCancer Genomics	2010	158
p53 as a New Prognostic Factor for Lymph Node Metastasis in Penile Carcinoma: Analysis of 82 Patients Treated with Amputation and Bilateral Lymphadenectomy Ademar Lopes, Artur Lício Rocha Bezerra, Clóvis Antônio Lopes Pinto, The Journal of Urology	2002	151
Gastrointestinal Involvement in Mantle Cell Lymphoma: A Prospective Clinic, Endoscopic, and Pathologic Study Antonio Salar, Núria Juanpere, Beatríz Bellosillo, The American Journal of Surgical Pathology ImmunologyGastroenterologyPathologyTract InvolvementSurgery	2006	140
High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy Teresa M. Cardesa‐Salzmann, Lluı́s Colomo, Gonzalo Gutiérrez, Haematologica	2011	128

Page 1